Herbimycin A, a tyrosine kinase inhibitor, impairs hypercalcemia associated with a human squamous cancer producing interleukin-6 in nude mice-Reference-Cited by-同舟云学术

Herbimycin A, a tyrosine kinase inhibitor, impairs hypercalcemia associated with a human squamous cancer producing interleukin-6 in nude mice

Published:2009-12-03 Issue:7 Volume:11 Page:905-911
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Moriyama Keiji,Williams Paul J.,Niewolna Maria,Dallas Mark R.,Uehara Yoshimasa,Mundy Gregory R.,Yoneda Toshiyuki

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Reference34 articles.

1. Interleukin-6 and its receptor: A paradigm for cytokines;Kishimoto;Science,1992

2. The biology of interleukin-6;Kishimoto;Blood,1989

3. Autoimmune conditions induced by epithelial solid tumors;Bataille;Rheumatol Int,1987

4. IFN-β2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines;Kirnbauer;J Immunol,1989

5. Interleukin-6 immunoreactivity in human tumors;Tabibzadeh;Am J Pathol,1989

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship of plasma bone cytokines with hypercalcemia in cancer patients;Clinica Chimica Acta;2000-12

2. New developments in IL-6 dependent biology and therapy: where do we stand and what are the options?;Expert Opinion on Investigational Drugs;1999-09

3. Combination of Interleukin-6 and Soluble Interleukin-6 Receptors Induces Differentiation and Activation of JAK-STAT and MAP Kinase Pathways in MG-63 Human Osteoblastic Cells;Journal of Bone and Mineral Research;1998-05-01